|  |
| |
| Figure 2: Graphical illustration of the NANOG protein sequence (A) and secondary structure motifs of the NANOG protein (B). |
| |
Description | NANOG mRNA variants NANOG-001 and -002 encode for a protein with a length of 305 amino acid (aa) and 289 aa, respectively. NANOG-004 is putatively protein coding; translation would result in a 186 aa long protein. NANOG-001, the 305 aa long protein with a molecular weight of 34.6 kDa is usually analyzed to study the role of NANOG (Fig. 2A). It consists of a Serine-, Threonine- and Proline-rich N-terminal region as well as eight W-repeats at its C-terminus (aa 104-151). The DNA-binding facilitating homeodomain spans from aa 95-155. Formation of secondary structures (helix, strand and turn) occurs mainly within the homeobox-coding region (Fig. 2B). The NANOG protein is unstable with a half-life of 120 min in human ESCs (Ramakrishna et al., 2011). |
Expression | NANOG is expressed in undifferentiated embryonic stem cells (ESCs) (Ezeh et al., 2005), glioma stem cells (Zbinden et al., 2010), fetal gonocytes (Hart et al., 2005; Hoei-Hansen et al., 2005), carcinoma-in-situ (CIS) of the testis (Hart et al., 2005; Hoei-Hansen et al., 2005), seminoma (Ezeh et al., 2005; Hoei-Hansen et al., 2005), embryonal carcinoma (Hoei-Hansen et al., 2005) and mammary carcinoma / breast cancer (Ezeh et al., 2005). Ezeh et al. found NANOG expression in adult germ cells throughout germ cell differentiation (spermatogonia to spermatids) (Ezeh et al., 2005). In contrast to the data of Ezeh et al., Hoei-Hansen et al. were unable to detect NANOG protein in adult testis tissue (Hoei-Hansen et al., 2005). NANOG is also expressed in the seminoma cell line TCam-2 and the embryonal carcinoma cell lines 2102EP, NCCIT, Tera-1, Tera-2, NT2/D1 and 833Ke (Nettersheim et al., 2011a; Nettersheim et al., 2011b; Eckert et al., 2008; You et al., 2009; Deb-Rinker et al., 2005; Freberg et al., 2007). In germ cell tumors (GCTs), NANOG expression is regulated by binding of OCT3/4 and SOX2 (SOX17 putatively in seminomas) to the NANOG promoter (Nettersheim et al., 2011a). Furthermore, in GCTs NANOG expression can be epigenetically suppressed by DNA-methylation of CpG-dinucleotides in the promoter (Nettersheim et al., 2011a). NANOG expression correlates to the differentiation status of GCTs, i.e. the more differentiated the GCT, the lower the NANOG expression (Nettersheim et al., 2011a). Expression of the NANOG pseudogene NANOGP8 has been detected in uterine cervix tumor tissue, breast tumor tissue, urinary bladder tissue and smooth muscle cells as well as in the cell lines OS732, HepG3 and MCF-7 (Zhang et al., 2006; Ambady et al., 2010). Expression of pseudogenes NANOGP4 and NANOGP5 has been demonstrated in the cell lines OS732, HepG3 and MCF-7, too (Zhang et al., 2006). |
Localisation | Nuclear. |
Function | NANOG promotes self-renewal and maintains pluripotency in undifferentiated cells, like ESCs (Boyer et al., 2005; Wang et al., 2006). Thereby, NANOG acts in concert with the transcription factors SOX2, OCT3/4 (POU5F1) and FOXD3 (Pan and Thomson, 2007) (Wang et al., 2006). NANOG activates expression of SOX2 and OCT3/4 (Pan and Thomson, 2007). A NANOG knock-down leads to differentiation of ESCs into the extraembryonic endoderm and trophectoderm lineages (Hyslop et al., 2005), demonstrating NANOG's important role in repression of differentiation. However, siRNA/shRNA-mediated reduction of the NANOG protein in the seminoma cell line TCam-2 is tolerated without induction of differentiation (Nettersheim et al., 2011b). It is assumed that the observed upregulation of OCT3/4 and SOX17 compensates for reduced NANOG levels in TCam-2 cells (Nettersheim et al., 2011b). NANOG-shRNA transduced cancer cells exhibit decreased long-term clonal and clonogenic growth, reduced proliferation and altered differentiation (Jeter et al., 2009). Overexpression of NANOG in ESC enables their feeder-cell-free propagation for multiple passages during which the cells remain pluripotent (Darr et al., 2006). NANOG is able to modulate gliomasphere clonogenicity and CD133+ stem cell behaviour (Zbinden et al., 2010). There, NANOG is regulated by the Hedgehog-GLI signalling pathway. GLI1 requires NANOG activity to form a positive loop, which is negatively controlled by p53 and vice versa (Zbinden et al., 2010). Besides SOX2 and OCT3/4, protein interaction databases predict interaction of NANOG with SALL4, KLF4, ZFP42, ISYNA1, LIN28, FAM48A, SMAD1, GATA6, RIF1, TRIM28, SMARCA4 and SMARCA2 (by similarity) (String 9.0, UniProt, I2D). |
Homology | NANOG and its pseudogenes (except NANOGP8) are present at their expected orthologous chromosomal positions in the chimpanzee genome when compared to the human genome (Fairbanks and Maughan, 2006). NANOGP8 is not found in the genome of the chimpanzee (Fairbanks and Maughan, 2006). The homeodomain of the human NANOG protein shares 87% identity to the murine NANOG homeodomain (Hart et al., 2004). A sequence comparison of murine, cow, chimp and human Nanog/NANOG promoters revealed that the CpG-dinucleotides are completely conserved in chimp and human (Nettersheim et al., 2011a). |
Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. |
Ambady S, Malcuit C, Kashpur O, Kole D, Holmes WF, Hedblom E, Page RL, Dominko T. |
Int J Dev Biol. 2010;54(11-12):1743-54. |
PMID 21136380 |
|
Eleven daughters of NANOG. |
Booth HA, Holland PW. |
Genomics. 2004 Aug;84(2):229-38. |
PMID 15233988 |
|
Core transcriptional regulatory circuitry in human embryonic stem cells. |
Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. |
Cell. 2005 Sep 23;122(6):947-56. |
PMID 16153702 |
|
Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. |
Darr H, Mayshar Y, Benvenisty N. |
Development. 2006 Mar;133(6):1193-201. |
PMID 16501172 |
|
Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. |
Deb-Rinker P, Ly D, Jezierski A, Sikorska M, Walker PR. |
J Biol Chem. 2005 Feb 25;280(8):6257-60. Epub 2004 Dec 21. |
PMID 15615706 |
|
TCam-2 but not JKT-1 cells resemble seminoma in cell culture. |
Eckert D, Nettersheim D, Heukamp LC, Kitazawa S, Biermann K, Schorle H. |
Cell Tissue Res. 2008 Feb;331(2):529-38. Epub 2007 Nov 15. |
PMID 18008088 |
|
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. |
Ezeh UI, Turek PJ, Reijo RA, Clark AT. |
Cancer. 2005 Nov 15;104(10):2255-65. |
PMID 16228988 |
|
Evolution of the NANOG pseudogene family in the human and chimpanzee genomes. |
Fairbanks DJ, Maughan PJ. |
BMC Evol Biol. 2006 Feb 9;6:12. |
PMID 16469101 |
|
Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. |
Freberg CT, Dahl JA, Timoskainen S, Collas P. |
Mol Biol Cell. 2007 May;18(5):1543-53. Epub 2007 Feb 21. |
PMID 17314394 |
|
The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. |
Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, Chow CW, Robb L. |
Cancer. 2005 Nov 15;104(10):2092-8. |
PMID 16206293 |
|
Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. |
Hoei-Hansen CE, Almstrup K, Nielsen JE, Brask Sonne S, Graem N, Skakkebaek NE, Leffers H, Rajpert-De Meyts E. |
Histopathology. 2005 Jul;47(1):48-56. |
PMID 15982323 |
|
Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. |
Hyslop L, Stojkovic M, Armstrong L, Walter T, Stojkovic P, Przyborski S, Herbert M, Murdoch A, Strachan T, Lako M. |
Stem Cells. 2005 Sep;23(8):1035-43. Epub 2005 Jun 27. |
PMID 15983365 |
|
Functional evidence that the self-renewal gene NANOG regulates human tumor development. |
Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. |
Stem Cells. 2009 May;27(5):993-1005. |
PMID 19415763 |
|
Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. |
Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, Nakatsuji N, Tada T. |
Mol Cell Biol. 2005 Mar;25(6):2475-85. |
PMID 15743839 |
|
Role of gain of 12p in germ cell tumour development. |
Looijenga LH, Zafarana G, Grygalewicz B, Summersgill B, Debiec-Rychter M, Veltman J, Schoenmakers EF, Rodriguez S, Jafer O, Clark J, van Kessel AG, Shipley J, van Gurp RJ, Gillis AJ, Oosterhuis JW. |
APMIS. 2003 Jan;111(1):161-71; discussion 172-3. |
PMID 12752258 |
|
TGF-b1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma. |
Nettersheim D, Gillis AJ, Looijenga LH, Schorle H. |
Int J Androl. 2011c Aug;34(4 Pt 2):e189-203. doi: 10.1111/j.1365-2605.2011.01172.x. Epub 2011 Jun 8. |
PMID 21649665 |
|
Nanog and transcriptional networks in embryonic stem cell pluripotency. |
Pan G, Thomson JA. |
Cell Res. 2007 Jan;17(1):42-9. |
PMID 17211451 |
|
PEST motif sequence regulating human NANOG for proteasomal degradation. |
Ramakrishna S, Suresh B, Lim KH, Cha BH, Lee SH, Kim KS, Baek KH. |
Stem Cells Dev. 2011 Sep;20(9):1511-9. Epub 2011 Mar 12. |
PMID 21299413 |
|
Transcriptional regulation of nanog by OCT4 and SOX2. |
Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH, Robson P. |
J Biol Chem. 2005 Jul 1;280(26):24731-7. Epub 2005 Apr 27. |
PMID 15860457 |
|
Nanog regulates self-renewal of cancer stem cell through IGF pathway in human hepatocellular carcinoma. |
Shan J, Shen J, Liu L, Xia F, Xu C, Duan G, Xu Y, Ma Q, Yang Z, Zhang Q, Ma L, Liu J, Xu S, Yan X, Bie P, Cui Y, Bian XW, Qian C. |
Hepatology. 2012 Apr 2. doi: 10.1002/hep.25745. [Epub ahead of print] |
PMID 22473773 |
|
A protein interaction network for pluripotency of embryonic stem cells. |
Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. |
Nature. 2006 Nov 16;444(7117):364-8. Epub 2006 Nov 8. |
PMID 17093407 |
|
Isolation and characterization of the murine Nanog gene promoter. |
Wu da Y, Yao Z. |
Cell Res. 2005 May;15(5):317-24. |
PMID 15916719 |
|
Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression. |
You JS, Kang JK, Seo DW, Park JH, Park JW, Lee JC, Jeon YJ, Cho EJ, Han JW. |
Cancer Res. 2009 Jul 15;69(14):5716-25. Epub 2009 Jun 30. |
PMID 19567677 |
|
NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. |
Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I, Ruiz i Altaba A. |
EMBO J. 2010 Aug 4;29(15):2659-74. Epub 2010 Jun 25. |
PMID 20581802 |
|
NANOGP8 is a retrogene expressed in cancers. |
Zhang J, Wang X, Li M, Han J, Chen B, Wang B, Dai J. |
FEBS J. 2006 Apr;273(8):1723-30. |
PMID 16623708 |
|